Terms: = Thyroid cancer AND DDX3X, DDX14, 1654, ENSG00000215301, DBX, DDX3, HLP2 AND Treatment
3 results:
1. Consumption of health resources in older people with differentiated thyroid carcinoma: a multicenter analysis.
Díez JJ; Anda E; Alcazar V; Isidro ML; Familiar C; Paja M; Martín Rojas-Marcos P; Pérez-Corral B; Navarro E; Romero-Lluch AR; Oleaga A; Pamplona MJ; Fernández-García JC; Megía A; Manjón-Miguélez L; Sánchez-Ragnarsson C; Iglesias P; Sastre J
Endocrine; 2023 Sep; 81(3):521-531. PubMed ID: 37103683
[TBL] [Abstract] [Full Text] [Related]
2. Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma--a systematic review.
Clement SC; Peeters RP; Ronckers CM; Links TP; van den Heuvel-Eibrink MM; Nieveen van Dijkum EJ; van Rijn RR; van der Pal HJ; Neggers SJ; Kremer LC; van Eck-Smit BL; van Santen HM
Cancer Treat Rev; 2015 Dec; 41(10):925-34. PubMed ID: 26421813
[TBL] [Abstract] [Full Text] [Related]
3. Survival and prognostic factors in a series of adults with medulloblastomas.
Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T
J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
[TBL] [Abstract] [Full Text] [Related]
